Mitja J. Lainscak

Q: What Schools Are Affiliated With Mitja J. Lainscak

Mitja J. Lainscak is affiliated with the following schools: University of Ljubljana, University of Maribor

Mitja J. Lainscak's AcademicInfluence.com Rankings

Mitja J. Lainscak

Medical

#2918

World Rank

#3362

Historical Rank

Cardiology

#289

World Rank

#295

Historical Rank

medical Degrees

Download Badge

Medical

Mitja J. Lainscak's Degrees

Doctorate Medicine University of Ljubljana
PhD Cardiology University of Ljubljana

Why Is Mitja J. Lainscak Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Mitja J. Lainscak's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. (2021) (2883)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial (2017) (713)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry (2013) (577)
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial (2017) (558)
Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry (2017) (475)
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology (2019) (469)
Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (2018) (402)
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions (2016) (399)
Self‐care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology (2011) (356)
Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations (2019) (335)
Cardiac cachexia: a systematic overview. (2009) (326)
Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure (2019) (308)
Sarcopenia: A Time for Action. An SCWD Position Paper (2019) (288)
European Society of Cardiology Heart Failure Long‐Term Registry (ESC‐HF‐LT): 1‐year follow‐up outcomes and differences across regions (2017) (241)
Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2017) (231)
European Society of Cardiology Heart Failure Association Standards for delivering heart failure care (2011) (223)
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2022) (201)
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2018) (191)
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial (2011) (166)
Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology (2020) (155)
The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study (2010) (149)
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. (2016) (145)
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study (2012) (141)
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease (2011) (140)
The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review (2016) (128)
Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology (2018) (125)
Acute heart failure congestion and perfusion status – impact of the clinical classification on in‐hospital and long‐term outcomes; insights from the ESC‐EORP‐HFA Heart Failure Long‐Term Registry (2019) (121)
Cachexia as a major public health problem: frequent, costly, and deadly (2013) (120)
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge (2018) (118)
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio‐Oncology Study Group of the Heart Failure Association and the Cardio‐Oncology Council of the European Society of Cardiology (2020) (118)
Drug-drug interaction software in clinical practice: a systematic review (2015) (116)
The obesity paradox in chronic disease: facts and numbers (2012) (114)
Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) (2018) (111)
Self‐care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology (2020) (108)
Factors related to self-care behaviours in heart failure: A systematic review of European Heart Failure Self-Care Behaviour Scale studies (2017) (107)
Heart Failure Association of the European Society of Cardiology position paper on frailty in patients with heart failure (2019) (106)
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology (2018) (104)
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology (2021) (102)
Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone. (2015) (101)
Cardiac cachexia: hic et nunc (2016) (99)
The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure. (2016) (99)
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. (2013) (96)
Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. (2009) (96)
Body composition changes in patients with systolic heart failure treated with beta blockers: a pilot study. (2006) (92)
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review (2013) (91)
Under-representation of elderly and women in clinical trials. (2017) (87)
Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology (2020) (85)
Request for regulatory guidance for cancer cachexia intervention trials (2015) (85)
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) (2010) (83)
Characteristics, treatments and 1‐year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long‐Term Registry (2018) (80)
Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers. (2009) (77)
Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial. (2011) (76)
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. (2016) (76)
Recall of lifestyle advice in patients recently hospitalised with heart failure: A EuroHeart Failure Survey analysis (2007) (75)
Comprehensive in‐hospital monitoring in acute heart failure: applications for clinical practice and future directions for research. A statement from the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2018) (75)
Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2018) (74)
International variations in the treatment and co‐morbidity of left ventricular systolic dysfunction: Data from the EuroHeart Failure Survey (2007) (73)
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups (2013) (72)
The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019 (2021) (72)
Cachexia: common, deadly, with an urgent need for precise definition and new therapies. (2008) (71)
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study (2013) (70)
Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure (2020) (69)
Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC‐HFA‐EORP Heart Failure Long‐Term Registry (2020) (67)
Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease. (2012) (66)
Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications. (2016) (64)
Self‐rated health and mortality in patients with chronic heart failure (2009) (62)
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life (2018) (61)
Atrial fibrillation in chronic non-cardiac disease: where do we stand? (2008) (61)
Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. (2014) (59)
Twenty‐four‐hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy (2015) (58)
Patient's View of Heart Failure: From the Understanding to the Quality of Life (2003) (57)
Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry (2019) (57)
Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial). (2015) (57)
Discharge coordinator intervention prevents hospitalizations in patients with COPD: a randomized controlled trial. (2012) (56)
Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF) (2017) (55)
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial (2008) (54)
Mechanism and novel therapeutic approaches to wasting in chronic disease. (2013) (54)
Exercise-Induced Changes in Iron Status and Hepcidin Response in Female Runners (2013) (53)
Anaemia is an independent predictor of death in patients hospitalized for acute heart failure (2010) (51)
Nonpharmacologic measures and drug compliance in patients with heart failure: data from the EuroHeart Failure Survey. (2007) (51)
Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. (2016) (50)
The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure (2009) (50)
Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia (2011) (49)
Emerging Biomarkers in Heart Failure and Cardiac Cachexia (2014) (49)
Cancer Cachexia and Related Metabolic Dysfunction (2020) (48)
Heart Failure Association of the European Society of Cardiology Specialist Heart Failure Curriculum (2014) (47)
To eat or not to eat? Indicators for reduced food intake in 91,245 patients hospitalized on nutritionDays 2006-2014 in 56 countries worldwide: a descriptive analysis. (2016) (47)
Association of adiponectin with peripheral muscle status in elderly patients with heart failure. (2013) (47)
National trends in heart failure hospitalization rates in Slovenia 2004–2012 (2016) (47)
The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose (2006) (45)
Muscle wasting as an independent predictor of survival in patients with chronic heart failure (2020) (44)
The effects of 8 weeks of endurance running on hepcidin concentrations, inflammatory parameters, and iron status in female runners. (2012) (44)
Clinical-pharmacist intervention reduces clinically relevant drug-drug interactions in patients with heart failure: A randomized, double-blind, controlled trial. (2016) (44)
Evaluation of an individualized dose titration regimen of patiromer to prevent hyperkalaemia in patients with heart failure and chronic kidney disease (2018) (43)
Imaging in patients with suspected acute heart failure: timeline approach position statement on behalf of the Heart Failure Association of the European Society of Cardiology (2019) (42)
Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease. (2019) (42)
Self‐rated health, nutritional intake and mortality in adult hospitalized patients (2014) (41)
Cytokine Response of Cultured Skeletal Muscle Cells Stimulated with Proinflammatory Factors Depends on Differentiation Stage (2013) (41)
Treatment of chronic heart failure with carvedilol in daily practice: the SATELLITE survey experience. (2007) (40)
Long‐term effects of patiromer for hyperkalaemia treatment in patients with mild heart failure and diabetic nephropathy on angiotensin‐converting enzymes/angiotensin receptor blockers: results from AMETHYST‐DN (2018) (40)
How does cachexia influence survival in cancer, heart failure and other chronic diseases? (2007) (39)
Self-rated health predicts acute exacerbations and hospitalizations in patients with COPD. (2010) (39)
Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia. (2017) (38)
Effect of selective and non-selective β-blockers on body weight, insulin resistance and leptin concentration in chronic heart failure (2007) (37)
Validation of Self Assessment Patient Knowledge Questionnaire for Heart Failure Patients (2005) (36)
Sarcopenia in Advanced COPD Affects Cardiometabolic Risk Reduction by Short-Term High-intensity Pulmonary Rehabilitation. (2016) (36)
Influence of cancer cachexia on drug liver metabolism and renal elimination in rats (2015) (36)
Mini nutritional assessment, body composition, and hospitalisations in patients with chronic obstructive pulmonary disease. (2011) (36)
Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction (2015) (36)
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease (2014) (35)
Fluid Therapy: Double-Edged Sword during Critical Care? (2015) (35)
Heart rate and its reduction in chronic heart failure and beyond (2017) (35)
Atrial natriuretic peptide and related peptides (2007) (33)
Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity (2014) (32)
Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world (2019) (32)
Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document (2020) (31)
ACT‐ONE ‐ ACTION at last on cancer cachexia by adapting a novel action beta‐blocker (2016) (30)
Neurological and endocrinological disorders: orphans in chronic obstructive pulmonary disease. (2011) (30)
Heart rate following short‐term beta‐blocker titration predicts all‐cause mortality in elderly chronic heart failure patients: insights from the CIBIS‐ELD trial (2014) (30)
Impact of the β1‐Adrenoceptor Arg389Gly Polymorphism on Heart‐Rate Responses to Bisoprolol and Carvedilol in Heart‐Failure Patients (2012) (29)
Biomarkers for Chronic Heart Failure (2009) (29)
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC‐EORP Heart Failure Long‐Term Registry (2020) (28)
Adherence to treatment guidelines and long-term survival in hospitalized patients with chronic obstructive pulmonary disease. (2011) (28)
Association between potassium level and outcomes in heart failure with reduced ejection fraction: a cohort study from the Swedish Heart Failure Registry (2020) (28)
Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges (2015) (27)
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review (2009) (27)
Doping awareness, views, and experience: a comparison between general practitioners and pharmacists (2011) (25)
Clinical trials update from the Heart Failure Society of America Meeting 2009: FAST, IMPROVE‐HF, COACH galectin‐3 substudy, HF‐ACTION nuclear substudy, DAD‐HF, and MARVEL‐1 (2010) (25)
Ghrelin and neurohumoral antagonists in the treatment of cachexia associated with cardiopulmonary disease. (2006) (25)
Patients' knowledge and beta blocker treatment improve prognosis of patients from a heart failure clinic (2006) (25)
What does the lay public know about heart failure? Findings from the Heart Failure Awareness Day Initiative (2016) (25)
The Effect of 4-week Rehabilitation on Heart Rate Variability and QTc Interval in Patients with Chronic Obstructive Pulmonary Disease (2014) (25)
Measuring self-care in patients with heart failure: A review of the psychometric properties of the European Heart Failure Self-Care Behaviour Scale (EHFScBS). (2017) (24)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology (2022) (24)
COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology (2021) (24)
Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD) (2018) (24)
Recommendations on sub-speciality accreditation in cardiology: The Coordination Task Force on Sub-speciality Accreditation of the European Board for the Speciality of Cardiology. (2007) (23)
Pharmacokinetics and pharmacodynamics of cardiovascular drugs in chronic heart failure. (2016) (23)
Effectiveness of discharge-coordinator intervention in patients with chronic obstructive pulmonary disease: study protocol of a randomized controlled clinical trial. (2011) (23)
Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly. (2012) (22)
Prognostic Factors in Chronic Heart Failure (2009) (22)
Infective endocarditis due to Abiotrophia defectiva: a report of two cases. (2005) (22)
Prognostic performance of serial in‐hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study (2018) (22)
Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling (2010) (22)
A comprehensive characterization of acute heart failure with preserved versus mildly reduced versus reduced ejection fraction – insights from the ESC‐HFA EORP Heart Failure Long‐Term Registry (2021) (21)
General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011 (2014) (21)
Herpes simplex virus infection limited to the brainstem (2005) (20)
Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable (2019) (20)
‘heartfailurematters.org’, an educational website for patients and carers from the Heart Failure Association of the European Society of Cardiology: objectives, use and future directions (2017) (20)
Iron deficiency in heart failure (2021) (20)
Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial. (2012) (19)
The Heart Failure Association Atlas: rationale, objectives, and methods (2020) (19)
Implementation of guidelines for management of heart failure in heart failure clinic: effects beyond pharmacological treatment. (2004) (19)
Metabolic disturbances in chronic heart failure: A case for the “macho” approach with testosterone?! (2007) (19)
Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Research Programme Heart Failure Long‐Term Registry (2020) (18)
Cardiac cachexia: hic et nunc: "hic et nunc" - here and now. (2015) (18)
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of bisoprolol, ramiprilat, propranolol and midazolam in rat dried blood spots. (2014) (18)
Return to work after acute myocardial infarction--listen to your doctor! (2008) (18)
Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia. (2014) (18)
Poor self-rated health predicts mortality in patients with stable chronic heart failure (2016) (18)
Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon? (2007) (17)
Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study (2016) (17)
European Society of Cardiology quality indicators for the care and outcomes of adults with heart failure. Developed by the Working Group for Heart Failure Quality Indicators in collaboration with the Heart Failure Association of the European Society of Cardiology (2022) (16)
Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease (2009) (16)
Distinct skeletal muscle molecular responses to pulmonary rehabilitation in chronic obstructive pulmonary disease: a cluster analysis (2019) (16)
Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women. (2011) (16)
Bone in heart failure (2020) (15)
Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease (2016) (15)
Relation of Longitudinal Changes in Quality of Life Assessments to Changes in Functional Capacity in Patients With Heart Failure With and Without Anemia. (2016) (15)
Right ventricular ejection fraction <20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients. (2012) (15)
Anticoagulants, antiplatelets, and statins in heart failure. (2008) (14)
‘Time is prognosis’ in heart failure: time‐to‐treatment initiation as a modifiable risk factor (2021) (14)
Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure. (2011) (14)
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study. (2012) (14)
Should procalcitonin be measured routinely in acute decompensated heart failure? (2015) (14)
Timely and individualized heart failure management: need for implementation into the new guidelines (2021) (14)
Heart failure clinic in a community hospital improves outcome in heart failure patients. (2006) (13)
Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure (2015) (13)
Mortality and readmissions in heart failure: an analysis of 36,824 elderly patients from the Slovenian national hospitalization database (2016) (12)
Chronic obstructive pulmonary disease patient journey: hospitalizations as window of opportunity for extra-pulmonary intervention (2013) (12)
Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure (2017) (12)
Biomarkers for chronic heart failure. (2007) (11)
Reproducibility of isokinetic knee testing using the novel isokinetic SMM iMoment dynamometer (2020) (11)
Estimation of renal function in lung cancer patients. (2012) (11)
Impact of chronic inflammatory airway disease on stroke severity and long-term survival after ischemic stroke - a retrospective analysis (2015) (11)
Herz Prognostic Factors in Chronic Heart Failure A Review of Serum Biomarkers , Metabolic Changes , Symptoms , and Scoring Systems (2009) (11)
Feasibility of transcutaneous electrical muscle stimulation in acute exacerbation of COPD (2011) (10)
Comorbidities in Chronic Obstructive Pulmonary Disease from Assessment to Treatment (2014) (10)
Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis. (2013) (10)
Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study (2013) (10)
Self‐care perception and behaviour in patients with heart failure: A qualitative and quantitative study (2021) (10)
IL-1RA Antibodies in Myocarditis after SARS-CoV-2 Vaccination (2022) (10)
Living with Chronic Heart Failure: Exploring Patient, Informal Caregiver, and Healthcare Professional Perceptions (2020) (10)
Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity (2018) (10)
Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two? (2010) (9)
Androgen status in non-diabetic elderly men with heart failure (2017) (9)
Methods and rationale of the DISCOVER CKD global observational study (2021) (9)
The PARADIGM of ARNI's: Assessing reasons for non-implementation in heart failure. (2016) (9)
Subcutaneous infection with Pseudallescheria boydii in an immunocompromised patient (2007) (9)
Heat shock protein 27 acts as a predictor of prognosis in chronic heart failure patients. (2017) (9)
Greater cardiovascular risk reduction with once-daily fixed combination of three antihypertensive agents and statin versus free-drug combination: The ALL-IN-ONE trial. (2016) (8)
Cancer cachexia: an orphan with a future (2019) (7)
Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure--insight from the Cardiac Insufficiency Bisoprolol Study in Elderly. (2012) (7)
In vitro Stability of Heat Shock Protein 27 in Serum and Plasma Under Different Pre-analytical Conditions: Implications for Large-Scale Clinical Studies (2016) (7)
Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy (2016) (7)
Regional differences in health-related quality of life in elderly heart failure patients: results from the CIBIS-ELD trial (2017) (7)
Effects of high-load and low-load resistance training in patients with coronary artery disease: rationale and design of a randomised controlled clinical trial (2021) (7)
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology. (2021) (7)
How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders. (2016) (6)
The management of patients with heart failure in a Slovenian community hospital: What has changed between 1997 and 2000? (2003) (6)
Heat shock protein 27 as a predictor of prognosis in patients admitted to hospital with acute COPD exacerbation (2019) (6)
Epidemiology and Prognosis of Heart Failure (2017) (6)
Doping and the Olympic games: the good, the bad, and the ugly (2008) (6)
Therapy modifications during hospitalization in patients with chronic heart failure. (2016) (5)
Corrigendum to ‘Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the Committee on Exercise Physiology and Training of the Heart Failure Association of the European Society of Cardiology’ [Eur J Heart Fail 2018;20:3–15] (2018) (5)
Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure (2015) (5)
10. Cardiovascular Risk in Chronic Kidney Disease (2009) (5)
Heart failure prevalence in the general population: SOBOTA‐HF study rationale and design (2019) (5)
Psychocardiology in the elderly (2016) (5)
Definition and Classification of Heart Failure (2017) (5)
Overview of emerging pharmacotherapy in chronic heart failure (2009) (5)
Use of Near Infrared Spectroscopy to Asses Remote Ischemic Preconditioning in Skeletal Muscle (2013) (5)
Challenges of Beta Blocker Therapy in Chronic Heart Failure: The Story Continues (2008) (4)
Education, knowledge, and self-management strategies in patients with chronic heart failure. (2010) (4)
Knowledge and skills required to perform point-of-care ultrasonography in family practice – a modified Delphi study among family physicians in Slovenia (2020) (4)
Atorvastatin modulates constitutive and lipopolysaccharide induced IL-6 secretion in precursors of human skeletal muscle (2012) (4)
Electrocardiogram Analysis and Survival of Patients With Chronic Obstructive Pulmonary Disease (2011) (4)
Echocardiographic predictors of outcome in patients with chronic obstructive pulmonary disease (2017) (4)
PURE muscle and more. (2016) (4)
Venous thromboembolism prophylaxis in hospitalized patients with pneumonia: a prospective survey (2009) (4)
Sodium–glucose cotransporter 2 inhibitor‐induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction (2021) (4)
Hemodynamic Response to High- and Low-Load Resistance Exercise in Patients with Coronary Artery Disease: A Randomized, Crossover Clinical Trial (2021) (4)
Natriuretic peptides for heart failure screening in nursing homes: a systematic review (2020) (3)
Biological and chronological age in heart failure: role of immunosenescence. (2016) (3)
Monday, 27 August 2012 (2012) (3)
Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology (2022) (3)
Objectively Measured Physical Activity in Patients with Coronary Artery Disease: A Cross-Validation Study (2021) (3)
SepsEast and COVID-19: Time to Make a Difference (2020) (3)
No train, no gain: does this apply to heart failure with preserved ejection fraction? (2013) (3)
349 Self‐rated health in patients with chronic heart failure: distribution and association with mortality (2008) (3)
A MULTICENTER STUDY OF DOSE TITRATION OF THE ORAL POTASSIUM BINDER RLY5016 TO MAINTAIN NORMAL SERUM POTASSIUM IN PATIENTS WITH HEART FAILURE AND CHRONIC KIDNEY DISEASE TREATED WITH RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITORS AND/OR ?-BLOCKERS (2011) (3)
Weight loss, food intake and mortality in hospitalized patients with chronic obstructive pulmonary disease (COPD) : The NutritionDay survey analysis (2016) (3)
Co-morbidity (HFrEF and HFpEF): atrial fibrillation (2018) (3)
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with RAAS-inhibitors-Coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology (2018) (3)
The Prevalence of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction and its Association with Elevated Pulmonary Pressure, Reduced Exercise Capacity and Quality of Life (2015) (3)
Treatment of pulmonary hypertension: bench to bedside. (2011) (3)
Procalcitonin in heart failure: hic et nunc. (2017) (3)
Inflammatory in Hear t Failure Revisited: Much More than Innocent Bystanders (2009) (3)
Validation of the FEW16 questionnaire for the assessment of physical well‐being in patients with heart failure with reduced ejection fraction: results from the CIBIS‐ELD study (2015) (3)
ASSOCIATION BETWEEN SERUM POTASSIUM LEVEL AND OUTCOMES IN HEART FAILURE WITH REDUCED EJECTION FRACTION: A COHORT STUDY FROM THE SWEDISH HEART FAILURE REGISTRY (2017) (2)
Chronic Heart Failure in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Prevalence, Clinical Characteristics, Treatment and Mortality (2009) (2)
Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology (2022) (2)
Management of patients with heart failure and secondary mitral regurgitation (2020) (2)
Fractional heat shock protein 27 urine excretion as a short-term predictor in acute exacerbation of chronic obstructive pulmonary disease (2021) (2)
Is blood flow restriction resistance training the missing piece in cardiac rehabilitation of frail patients? (2022) (2)
Pharmacotherapy adherence in patients with heart failure: Easier said than done. (2021) (2)
Importance of bedside echocardiography for detection of unsuspected isolated right ventricular infarction as a cause of cardiovascular collapse. (2007) (2)
Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls. (2020) (2)
How to relevantly measure the relevance of published articles? (2007) (2)
Impaired coordination of skeletal muscle protein turnover signalling in sarcopenic COPD patients (2016) (2)
Iron de ﬁ ciency in heart failure (2021) (2)
Unbiased analysis of skeletal muscle molecular responses upon pulmonary rehabilitation in advanced COPD (2018) (2)
Combined resistance training with aerobic training improves physical performance in patients with coronary artery disease: A secondary analysis of a randomized controlled clinical trial (2022) (2)
Regional differences in heart failure hospitalizations, mortality, and readmissions in Slovenia 2004–2012 (2019) (2)
Assessment of public awareness on chronic obstructive pulmonary disease in Slovenia (2014) (2)
High Non‐Specific T Lymphocyte Response to the Adjuvanted H1N1 Vaccine in Comparison with the H1N1/H3N2/B‐Brisbane Vaccine without Adjuvant (2012) (2)
Dietary Iron Intake and Biomarkers of Iron Status in Slovenian Population: Results of SI.Menu/Nutrihealth Study (2022) (2)
Clinical impact of anaemia in patients with chronic obstructive pulmonary disease: Results from ECLIPSE study (2012) (2)
Poster session Wednesday 11 December all day display: 11/12/2013, 09:30-16:00 * Location: Poster area (2013) (2)
Unsuccessful Desensitization to Paclitaxel in a Patient with High Basophil Sensitivity. (2020) (2)
LB023-MON SELF-RATED HEALTH, NUTRITIONAL STATUS AND NUTRITIONAL INTAKE PREDICT IN-HOSPITAL MORTALITY IN ADULT HOSPITALIZED PATIENTS: RESULTS OF A EUROPEAN-WIDE NUTRITIONDAY SURVEY (2013) (1)
COPD and comorbidities in heart failure: the next frontier of SGLT2 inhibitors? (2021) (1)
ANAEMIA AND SURVIVAL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2009) (1)
Metabolic risk factors in patients with advanced COPD and the response to short-term high-intensity pulmonary rehabilitation (2015) (1)
High-Load and Low-Load Resistance Exercise in Patients with Coronary Artery Disease: Feasibility and Safety of a Randomized Controlled Clinical Trial (2022) (1)
Left ventricular metastasis of soft tissue sarcoma causing heart failure: Presentation of two cases. (2016) (1)
Pulmonary Function During Beta-blocker Titration In Elderly Patients With Heart Failure: The CIBIS-ELD Analysis (2010) (1)
Atrial Fibrillation and Anticoagulant Therapy in Patients with Chronic Obstructive Pulmonary Disease. (2009) (1)
Measuring self-care behaviors in Slovenian patients with heart failure: pilot study (2018) (1)
Optimisation of Heart Failure Management in Nursing Homes Using Point-of-Care Ultrasonography: Harmonious Trial Rationale and Design (2020) (1)
ETHYLENE GLYCOL POISONING WITH CONCURRENT ETHANOL INGESTION (2003) (1)
Assessment of physical fitness in adults by field testing supported by the specific software for personal computer based use (2007) (1)
542 Pentoxifylline improves the haemoglobin levels in anaemic patients with chronic heart failure (2007) (1)
Abstracts of the 10th International Conference on Cachexia, Sarcopenia and Muscle Wasting, Rome, Italy, 8‐10 December 2017 (Part 2) (2018) (1)
Clinical profiles and outcomes of patients with chronic heart failure and chronic obstructive pulmonary disease: efficacy and safety of Ivabradine. a SHIFT study analysis (2013) (1)
Functional capacity in heart failure with preserved ejection fraction: looking for interactions and explanations. (2014) (1)
Beta-blockers in elderly patients with heart failure ready for prime time? (2009) (1)
POS-328 THE BURDEN OF HYPERKALEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2021) (1)
Intravenous ferric carboxymaltose improves quality of life in patients with chronic heart failure and iron deficiency regardless the presence of anaemia: an analysis from the FAIR-HF study (2010) (1)
Exercise training in cardiovascular disease: are we closing the gender gap? (2020) (1)
Clinical profile, outcomes, and ivabradine effects in patients with chronic obstructive pulmonary disease and chronic heart failure: The SHIFT trial analysis (2013) (1)
Nonlinear dynamics of heart rate variability in patients with chronic obstructive pulmonary disease and changes after 4-week rehabilitation (2014) (1)
P898Heart failure management and outcome is sex and age dependent: an analysis of the European Society of Cardiology Heart Failure Long-Term Registry (2018) (1)
Late-post-COVID-19 cerebral venous sinus thrombosis and stroke: a case report (2022) (1)
Phosphodiesterase Inhibitors (2019) (1)
Cardiovascular Disease and Cardiovascular Drugs in Patients with Chronic Obstructive Pulmonary Disease: Prevalence and Survival Analysis. (2009) (1)
Participation in a clinical trial is associated with lower mortality but not lower risk of HF hospitalization in patients with heart failure: observations from the ESC EORP Heart Failure Long-Term Registry (2023) (1)
Cardiovascular Function in Intensive Care Medicine or Homo Mensura Est (2016) (1)
The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy. (2018) (1)
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD). (2014) (1)
Smoking cessation in heart failure: easier said than done. (2009) (1)
Evaluating anxiety in elective coronary angiography study: rationale, design, and study methodology (2022) (1)
The heart failure specialists of tomorrow: a network for young cardiovascular scientists and clinicians (2020) (1)
Intentional hypoglycaemia in diabetic patients treated with insulin (2007) (0)
Antibiotic Treatment of Hospitalized Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Clinical Practice and Prognostic Implication (2011) (0)
To eat or not to eat? Indicators for reduced food intake in 91,245 patients hospitalized on nutritionDays 2006–2014 in 56 countries worldwide: a descriptive analysis 1,2 (2016) (0)
Results of the SepsEast Registry to define the Characteristics in Coronavirus Disease in Central-Eastern Europe between March 2020-February 2021: an international, multicentre retrospective study of the SEARCH-COVID-19 Study Group (2022) (0)
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology. (2022) (0)
Bisoprolol pharmacokinetics and body composition in patients with chronic heart failure: a longitudinal study (2016) (0)
Transvenous phrenic nerve stimulation to treat central sleep apnoea in patients with heart failure may improve sleep, quality of life, and symptoms. (2022) (0)
Chronic obstructive pulmonary disease and comorbidities in heart failure: the next frontier of sodium–glucose co‐transporter 2 inhibitors? (2021) (0)
Hemodynamic response to high and low load resistance exercise in patients with coronary artery disease: a crossover, randomised, clinical trial (2021) (0)
BLOOD PRESSURE MANAGEMENT IN PATIENTS AFTER HOSPITALIZATION FOR HEART FAILURE: P 555 (2004) (0)
Feasibility of early hospital discharge directly from coronary care unit after primary angioplasty for uncomplicated acute myocardial infarction (2009) (0)
PARTICIPATION IN A CLINICAL TRIAL IS ASSOCIATED WITH LOWER MORTALITY IN PATIENTS WITH HEART FAILURE: OBSERVATIONS FROM THE EUROBSERVATIONAL RESEARCH PROGRAMME OF THE EUROPEAN SOCIETY OF CARDIOLOGY HEART FAILURE LONG-TERM REGISTRY (2023) (0)
Diagnostic and therapeutic procedures during first hospitalization for advanced heart failure (2000) (0)
Heart failure pharmacotherapy guideline implementation and survival in patients from community hospital: a retrospective study (2014) (0)
Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (2012) (0)
Embracing secondary mitral regurgitation with Carillon: past, present, and future (2020) (0)
RESULTS OF »EUROHEART FAILURE« SURVEY IN SLOVENIA: CHARACTERISTICS AND DIAGNOSTIC PROCEDURES IN HOSPITALISED HEART FAILURE PATIENTS (2004) (0)
670 Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial (2008) (0)
Cardiac cachexia: hic et nunc: Cardiac cachexia (2016) (0)
P5404Depressive symptoms are major determinant of restricted health-related quality of life in patients with heart failure (2018) (0)
Impact of physical, sociodemographic, and psychological factors on return to work after acute coronary syndrome (2005) (0)
Optimising cardiopulmonary rehabilitation of long COVID-19 syndrome: are we there yet? (2022) (0)
Genes, Cells, and MiRNAs (2019) (0)
1404: Sociodemographic factors and quality of life in heart failure patients (2006) (0)
Nutritional status in the elderly: misbeliefs, misconceptions and the real world (2016) (0)
Fatigue and cachexia (2012) (0)
Balancing cardiac rehabilitation for elderly. (2020) (0)
Echocardiography and cardiac biomarkers in patients with lung cancer treated with platinum-based chemotherapy (2014) (0)
Variable physiological response to short-term high-intensity exercise training in men with advanced COPD (2015) (0)
Home-Based, Walking Exercise Behavior Change Intervention vs Usual Care for Adults With Peripheral Artery Disease. (2022) (0)
Heart failure with preserved ejection fraction in patients with chronic obstructive pulmonary disease exacerbation is associated with poor long-term survival (2013) (0)
Abstract 19027: Influence of Intravenous Ferric Carboxymaltose on Health-Related Quality of Life Measures in Patients with Chronic Heart Failure and Iron Deficiency: an Analysis from the FAIR-HF Study (2010) (0)
501 Body composition in patients with systolic heart failure treated with beta blockers (2004) (0)
Patient, Nurse, and Doctor Assessment of New York Heart Association Class, Health, and Quality of Life in Heart Failure: Comparison and Outcome Prediction (2010) (0)
Comment on: “Effects of resistance training intensity on muscle quantity/quality in middle‐aged and older people: a randomized controlled trial” by Otsuka et al. (2022) (0)
Metabolic profile of patients with chronic obstructive pulmonary disease in rehabilitation program (2014) (0)
Exercise intolerance in heart failure: beyond mitochondrial dysfunction. Letter regarding the article ‘Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?’ (2022) (0)
24 Response on Epoetin Treatment is Poor in Hemodialysed Patients with Low Creatinine and Albumin Values (2005) (0)
The efficacy of cardiac rehabilitation on exercise performance in men and women (2021) (0)
Drug-drug interaction software in clinical practice: a systematic review (2014) (0)
USE OF DRUGS AND PATIENT’S QUALITY OF LIFE IN HEART FAILURE CLINIC (2003) (0)
655 Beta blockers and patient's knowledge influence prognosis of patients from the heart failure clinic (2005) (0)
Response: Commentary: Blood Flow Restriction Exercise: Considerations of Methodology, Application, and Safety (2021) (0)
Beware of TOSCA's kiss or metabolic and hormonal aspects of heart failure. (2021) (0)
Transvenous Phrenic Nerve Stimulation Improves Central Sleep Apnea in Heart Failure Patients (2020) (0)
SELF-RATED HEALTH AND OUTCOME IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A PROSPECTIVE STUDY (2009) (0)
Abstract 13341: Beneficial Effects of Beta Blockers in Elderly Patients with Chronic Heart Failure Are Not Influenced by Cardiac Rhythm -- Insight From the Cardiac Insufficiency Bisoprolol Study in Elderly (2010) (0)
Survival and body fat in hemodialysis patients: true association or effects of concomitant therapy? (2006) (0)
Short-term weight loss after hospitalization predicts long-term survival in patients with chronic heart failure (2006) (0)
P0816CLINICAL CHARACTERISTICS AND EGFR AND UACR DISTRIBUTION ACCORDING TO THE 2012 KDIGO CKD CLASSIFICATION: A REPORT FROM THE US DISCOVER CKD COHORT (2020) (0)
Subgroup or Selection Bias (2010) (0)
Renal Function in Patients with Chronic Obstructive Pulmonary Disease. (2009) (0)
Insulin resistance, lipids and body composition in patients with coronary artery disease after combined aerobic training and resistance training: a randomised, controlled trial (2023) (0)
The estimation of comorbidities and serum concentration of cardiac biomarkers in patients with chronic obstructive pulmonary disease treated with invasive or nonivasive ventilation (2015) (0)
1405: Effects of music on State Anxiety Scores in patients undergoing echocardiography: Preliminary report of a randomized trial (2006) (0)
Sedentary behaviour and physical activity following multimodal exercise-based cardiac rehabilitation in patients with coronary artery disease (2022) (0)
698 Lifestyle advice in hospitalized heart failure patients: experience from the EuroHeart Failure survey (2006) (0)
TREATMENT OF HEART FAILURE PATIENTS IN UNIVERSITY AND GENERAL HOSPITAL IN 1997 (2003) (0)
OP040: Metabolic Syndrome, Diabetes and Body Composition in COPD Patients on Rehabilitation (2014) (0)
1361: Self Management Strategies in Chronic Heart Failure Patients: the Reasons for Inadequate Implementation (2004) (0)
Resistance training during cardiac rehabilitation improves physical performance in patients with coronary artery disease: a randomised controlled trial (2022) (0)
Prognostic role of body mass index after acute myocardial infarction. (2006) (0)
Anaemia in Patients Hospitalized for Acute Heart Failure (2009) (0)
POS-305 HOSPITALIZATIONS AND LENGTH OF STAY IN PATIENTS WITH CKD WITH AND WITHOUT HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2022) (0)
The 8th EFCC Continuous Postgraduate Course in Clinical Chemistry: New trends in classification, diagnosis and management of kidney diseases (2008) (0)
297 Management of patients with heart failure in a regional hospital: comparison of cardiologists and internists (2007) (0)
1464 Sociodemographic Predictors of Knowledge and Self-Management Measures in Heart Failure Patients: A Pilot Study (2005) (0)
Abstract 813: Liver Function Markers and Mortality in Patients with Chronic Heart Failure (2008) (0)
Regional differences in heart failure hospitalizations in Slovenia 2004-2012 (2016) (0)
Self-rated health, β-blockers and adverse events. (2014) (0)
FP10 Patients with Chronic Heart Failure Receive Insufficient Nonpharmacological Treatment Advice at Hospital Discharge (2009) (0)
Development of educational material for patients with heart failure (2018) (0)
Genetic polymorphisms of human cardiac troponins as an unrecognized challenge for diagnosing myocardial injury (2014) (0)
Cardiovascular outcomes in community-dwelling older adults with chronic obstructive pulmonary disease (2013) (0)
P4367HSP27 plasma levels predict prognosis in chronic heart failure patients (2017) (0)
Molecular signalling towards mitochondrial breakdown is enhanced in skeletal muscle of patients with chronic obstructive pulmonary disease (COPD) (2018) (0)
LB016-MON NUTRITIONAL STATUS AND BODY COMPOSITION IN CHRONIC CARDIOPULMONARY DISEASE (2013) (0)
POS-503 EVALUATING CHRONIC KIDNEY DISEASE PROGRESSION: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2021) (0)
Psychometric Properties of the Slovenian Version of the Cardiac Depression Scale (2022) (0)
Coronavirus-related stress, anxiety, and obsessive thinking in patients undergoing cardiac rehabilitation during the COVID19 pandemic (2022) (0)
The efficacy of high-load resistance training in combination with aerobic training in patients with coronary artery disease: a dose-dependent randomised, controlled clinical trial (2022) (0)
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association ( HFA ) of the ESC (2023) (0)
POS-329 TREATMENT PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT (2021) (0)
The effects of different types of resistance training in patients with coronary artery disease. (2022) (0)
Anabolic and Inflammatory Response to High- and Low-Load Resistance Training in Patients with Coronary Artery Disease: A Randomized Controlled Trial. (2023) (0)
2457Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the ESC-HF Long-Term Registry (2018) (0)
Depressive symptoms and health-related quality of life in patients with heart failure (2018) (0)
Balancing cardiac rehabilitation for elderly. (2020) (0)
P162Prognostic implication of body composition compartments and markers of its metabolism in non-cachectic men with chronic heart failure (2017) (0)
Assessment of quadricuspid aortic valve with real time three-dimensional transthoracic echocardiography (2013) (0)
From surveys to trials in the beta blocker world (2009) (0)
Battlescarred: subgroup or selection bias? (2010) (0)
Transvenous Phrenic Nerve Stimulation is Safe and Effective in Patients with Heart Failure and Cheyne-stokes Respiration (2020) (0)
1465 Long Term Improvement of Heart Failure Patient's Knowledge Receiving Care in The Heart Failure Clinic (2005) (0)
311 Who should assess symptoms, quality of life, and health in heart failure: patient, doctor or nurse? (2007) (0)
1386: Quality of life evaluation in heart failure: Patient, nurse or doctor? (2007) (0)
Physical activity and sedentary behaviour following combined aerobic and resistance training in coronary artery disease patients: A randomised controlled trial. (2022) (0)
Physical and psychological status of patients with COPD and impaired LVEF: Two bads don't make a good. (2017) (0)
Letter by Kambic et al Regarding Article, "A Randomized, Controlled Trial of Resistance Training Added to Caloric Restriction Plus Aerobic Exercise Training in Obese Heart Failure With Preserved Ejection Fraction". (2023) (0)
Hyponatraemia and changes in natraemia during hospitalization for acute heart failure and associations with in-hospital and long-term outcomes - from the ESC HFA EORP Heart Failure Long-Term Registry. (2023) (0)
Utvrđivanje komorbiditeta i serumske koncentracije srčanih biomarkera u pacijenata s kroničnom opstruktivnom plućnom bolesti liječenih invazivnom ili neinvazivnom ventilacijom (2015) (0)
MON-PP174: Evaluation of Nutritional Status with Six Nutrition Screening Tools and Bioimpedance in Hospitalized Patients (2015) (0)
Health-related behaviour among managers of Slovenian hospitals and institutes of public health (2015) (0)
Nonlinear Heart Rate Variability in Patients with Chronic Obstructive Pulmonary Disease and Changes after 4-week Comprehensive Inpatient Pulmonary Rehabilitation. (2022) (0)
Overviewofemerging pharmacotherapyinchronic heartfailure (2009) (0)
The Relationship between Serum Lipids and Survival in Patients Hospitalized With Heart Failure (2010) (0)
Drug interactions with carbamazepine: a case study of influence on anticoagulation treatment with warfarin (2007) (0)
Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure. (2023) (0)
NT-proBNP predicts the need for ventilatory support in the patients with acute exacerbation of chronic obstructive pulmonary disease (2015) (0)
NT-proBNP, troponin T and left ventricular function in patients with acute exacerbation of chronic obstructive pulmonary disease (2012) (0)
Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility (2022) (0)
SepsEast Registry indicates high mortality associated with COVID-19 caused acute respiratory failure in Central-Eastern European intensive care units (2022) (0)
P4541Sarcopenia in non-cachectic males with heart failure (2019) (0)
306 Clinical characteristics and long term mortality of patients with chronic obstructive pulmonary disease hospitalized for heart failure (2004) (0)
Effects of high- and low-load resistance training in patients with coronary artery disease: a randomized controlled clinical trial. (2022) (0)
Heat shock protein 27 as a predictor of prognosis in patients admitted to hospital with acute COPD exacerbation (2019) (0)
574 Are sociodemographic factors associated with patient knowledge and self management measures in heart failure patients (2006) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Mitja J. Lainscak?

Mitja J. Lainscak is affiliated with the following schools:

University of Ljubljana
University of Maribor